Results 181 to 190 of about 44,347 (208)
Some of the next articles are maybe not open access.
Pathological Potential of Astroglial Purinergic Receptors
2014Acute brain injury and neurodegenerative disorders may result in astroglial activation. Astrocytes are able to determine the progression and outcome of these neuropathologies in a beneficial or detrimental way. Nucleotides, e.g. adenosine 5'-triphosphate (ATP), released after acute or chronic neuronal injury, are important mediators of glial activation
Heike Franke, Peter Illes
openaire +3 more sources
Is the benzodiazepine receptor purinergic?
European Journal of Pharmacology, 1979H.W. Damm+2 more
openaire +3 more sources
Purinergic Receptors and Hepatobiliary Function
2003Publisher Summary This chapter describes the basic mechanisms that contribute to purinergic signaling in liver cells by focusing on a molecular and pharmacologic description of the receptors present, the mechanisms and regulation of adenosine triphosphate (ATP) release, and nucleotide/nucleoside degradation and reuptake pathways.
Andrew P. Feranchak, J. Gregory Fitz
openaire +2 more sources
Purinergic Receptors in the Nervous System
2003Publisher Summary This chapter focuses on the localization and roles of purinergic receptor subtypes in the central nervous system (CNS), as comprehensive reviews of purinergic signaling in the peripheral nervous system. The concept of purinergic neurotransmission is the existence of postjunctional purinergic receptors. A basis for distinguishing two
openaire +2 more sources
Molecular Recognition in Water Using Macrocyclic Synthetic Receptors
Chemical Reviews, 2021Luis Escobar, Pablo Ballester
exaly
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Barata, Brian I Rini
exaly
Recent Progress in the Management of Advanced Renal Cell Carcinoma
Ca-A Cancer Journal for Clinicians, 2007Brian I Rini
exaly
Structural diversity of G protein-coupled receptors and significance for drug discovery
Nature Reviews Drug Discovery, 2008Malin C Lagerström, Helgi B Schiöth
exaly
REV-ERB and ROR nuclear receptors as drug targets
Nature Reviews Drug Discovery, 2014Giuseppe Lippi+2 more
exaly